Low thyroid hormones (hypothyroidism) slow calorie burn, drain energy, and make weight loss frustratingly difficult
The post hoc analysis, which included the four SURMOUNT trials [1], compared tirzepatide with a placebo for up to 72 to 88 weeks in 4,677 adults (2,999 females, 1,678 males) living with obesity, highlighting potential sex differences in the response
Several studies found improved healing, reduced rates of leakage, and better tissue integrity at anastomotic sites in BPC-157-treated animals, findings with practical implications for surgical gastroenterology where anastomotic failure remains a serious complication
Similar content being viewed by others Introduction Type 2 diabetes mellitus (T2DM) and obesity pose a growing challenge to public health, with millions of people affected by these pathological conditions and socio-economic costs steadily increasing worldwide
Type 2 diabetes (both work well, semaglutide more studied)
PLEASE NOTE: The information provided on this page is intended for general informational purposes only